Cetuximab in Head and Neck Cancer Patients
Conditions: Head and Neck Cancer; Squamous Cell Carcinoma Intervention: Drug: Cetuximab Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI); National Institute of Dental and Craniofacial Research (NIDCR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials